ADCOCK INGRAM HOLDINGS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.78 ZAR | +4.76% |
|
+4.66% | -5.52% |
| Feb. 21 | Adcock Ingram Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Feb. 21 | Transcript : Adcock Ingram Holdings Limited, H1 2024 Earnings Call, Feb 21, 2024 |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -5.52% | 430M | B | ||
| +15.91% | 42.02B | B- | ||
| +22.40% | 21.66B | B+ | ||
| +18.48% | 15.09B | - | ||
| +16.12% | 14.21B | B+ | ||
| +45.12% | 12.37B | B | ||
| -0.05% | 6.79B | - | - | |
| -9.58% | 6.59B | B+ | ||
| -8.87% | 5.73B | - | - | |
| +14.18% | 5.56B | B+ |
Investor Rating
Trading Rating
-
ESG Refinitiv
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- AIP Stock
- Ratings Adcock Ingram Holdings Limited
